The British Pharmacopoeia 2020 is the latest edition of a publication that sets the standards for the quality of medicines in the United Kingdom. It is a comprehensive resource that contains information on the quality and purity of medicines, including pharmaceutical substances, excipients, and dosage forms. The BP 2020 is an essential reference for all those involved in the manufacture, testing, and distribution of medicines in the UK.
One of the key features of the British Pharmacopoeia 2020 is that it is updated regularly to reflect the latest scientific and regulatory developments. This ensures that the standards set out in the BP 2020 are up-to-date and relevant to the current practice of medicine. The BP 2020 contains over 4,000 monographs, which are detailed descriptions of individual substances and dosage forms. These monographs provide information on the quality and purity of the substances, as well as guidance on their use in medicines.
The British Pharmacopoeia 2020 is also an important resource for regulatory authorities, such as the Medicines and Healthcare products Regulatory Agency (MHRA). The standards set out in the BP 2020 are used by the MHRA to assess the quality and safety of medicines that are marketed in the UK. The BP 2020 is also used by the European Pharmacopoeia and the World Health Organization as a reference work.
The BP 2020 is available in a number of formats, including print, online, and CD-ROM. The online version of the BP 2020 is particularly useful as it allows users to search for specific substances or dosage forms quickly and easily. The online version also includes additional features, such as updates and news, which are not available in the print version.
One of the key benefits of using the British Pharmacopoeia 2020 is that it helps to ensure that medicines are of consistent quality. By setting out standards for the quality and purity of pharmaceutical substances, excipients, and dosage forms, BP 2020 helps to ensure that all medicines on the market are of a high standard. This helps to protect public health by ensuring that medicines are effective and safe to use.
In addition to setting standards for medicines, the British Pharmacopoeia 2020 also provides guidance on analytical methods for testing medicines. This helps to ensure that testing is carried out in a consistent and reliable manner, which is essential for ensuring the quality and safety of medicines.
Overall, the British Pharmacopoeia 2020 is an essential resource for anyone involved in the manufacture, testing, and distribution of medicines in the UK. It provides comprehensive information on the quality and purity of pharmaceutical substances, excipients, and dosage forms, as well as guidance on their use in medicines. By ensuring that medicines are of a consistent quality, the BP 2020 helps to protect public health and ensure that patients receive safe and effective treatments.
British Pharmacopoeia 2020
The BP 2020 has been Available from 1 August 2019 | Effective from 1 January 2020 | Superseding the BP 2019
The British Pharmacopoeia (BP) 2020 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
Why use the BP?
If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.
It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a monograph exists, medicinal products sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making it a comprehensive, value-for-money collection of UK and European standards. The BP 2019 supersedes the BP 2018 and becomes legally effective on 1 January 2019. This edition incorporates new BP and European Pharmacopoeia monographs and a significant number of revised monographs.
What's included?
In addition to all European Pharmacopoeia texts being included, the new edition also features:
- 35 new BP monographs, 53 new Ph. Eur. monographs
- 331 amended BP monographs
- All monographs from Ph. Eur. 10.0 are included.
ALSO READ: British Pharmacopoeia 2019
Tags
Pharmacopoeia
